Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026, Aug 2026 and Oct 2026.
- Largest single sale: $1.6M (25,000 shares) of Eton Pharmaceuticals, Inc. on Aug 24, 2026. Filing
- Last sale before this period: Jun 16, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | Mar 8, 2023 | Oct 6, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 6, 2026, Eton Pharmaceuticals, Inc.: sold 4,166 shares for $229K, no plan disclosed. 1 filing: 1
- Oct 2, 2026, Eton Pharmaceuticals, Inc.: 10,522 shares vested. 1 filing: 1
- Aug 24, 2026, Eton Pharmaceuticals, Inc.: sold 25,000 shares for $1.6M, no plan disclosed; 25,000 shares acquired by exercising options. 1 filing: 1
- Jul 31, 2026, Eton Pharmaceuticals, Inc.: 128,985 shares awarded. 1 filing: 1
- Jul 12, 2026, Eton Pharmaceuticals, Inc.: 10,000 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.